Search

everythinglearnresearchcommunity

for

Search:↓

Research 10 of 14

1. Safety and effectiveness of sacituzumab govitecan in patients with metastatic triple-negative breast cancer in real-world settings: first observations from an interdisciplinary breast cancer centre in Germany Therapeutic Advances in Medical Oncology · 2023 · 34 citations
2. Health-related quality of life with sacituzumab govitecan in HR+/HER2− metastatic breast cancer in the phase III TROPiCS-02 trial The Oncologist · 2024 · 9 citations
3. Sacituzumab Govitecan-Hziy (Trodelvy™) Oncology Times · 2021 · 3 citations
4. Clinical perspective on management of key adverse events with sacituzumab govitecan The Oncologist · 2025 · 1 citations
5. Canadian Expert Recommendations on Safety Overview and Toxicity Management Strategies for Sacituzumab Govitecan Based on Use in Metastatic Triple-Negative Breast Cancer Current Oncology · 2024 · 6 citations
6. A plain language summary of quality of life with sacituzumab govitecan treatment in the TROPiCS-02 study in participants with breast cancer (HR-positive/HER2-negative) Future Oncology · 2025
7. Antibody-drug conjugate induced hair loss responds to minoxidil: A case report SKIN The Journal of Cutaneous Medicine · 2025
8. Sacituzumab tirumotecan (sac-TMT/MK-2870/SKB264): a novel antibody–drug conjugate in breast cancer Oncology Reviews · 2026
9. Real-world pharmacovigilance insights into drug-induced risk of alopecia Frontiers in Pharmacology · 2025
10. Improving Quality of Life During Chemotherapy: Cannabinoids, Cryotherapy, and Scalp Cooling American Society of Clinical Oncology Educational Book · 2023 · 6 citations

Community

— no results